Back to search

Netherlands· NL-ed6387d1693f

Boostrix Polio, suspensie voor injectie in voorgevulde spuit

A diphtherie-pertussis-poliomyelitis-tetanus product containing difterietoxoïde, geadsorbeerd, geinactiveerd + pertactine (69kd buitenmembraan proteine) + pertussis, filamenteus haemagglutinine, geadsorbeerd + pertussistoxoïde, geinactiveerd, geadsorbeerd, registered in Netherlands by GlaxoSmithKline B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC J07CA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBoostrix Polio, suspensie voor inject…ATCJ07CA02REGISTER NO.NL-ed6387d1693fPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Diphtherie-pertussis-poliomyelitis-tetanus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07CA02 (diphtherie-pertussis-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Diphtherie-pertussis-poliomyelitis-tetanus · ATC J07CA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DIFTERIETOXOÏDE, GEADSORBEERD, GEINACTIVEERD + PERTACTINE (69KD Buitenmembraan Proteine) + PERTUSSIS, FILAMENTEUS HAEMAGGLUTININE, GEADSORBEERD + PERTUSSISTOXOÏDE, GEINACTIVEERD, GEADSORBEERD
Manufacturer
GlaxoSmithKline B.V.
Country
Netherlands (NL)
ATC code
J07CA02
ATC class
Diphtherie-Pertussis-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    35123

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5120f432-f41c-4322-afc3-4cb6f65f671b
GET /v1/drugs/5120f432-f41c-4322-afc3-4cb6f65f671b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h35123_smpc.pdf",
  "strength": null,
  "atc_label": "Diphtheria-Pertussis-Poliomyelitis-Tetanus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg35123",
  "excipients": [
    "ALUMINIUMFOSFAAT, GEHYDRATEERD",
    "ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
    "MEDIUM 199",
    "NATRIUMCHLORIDE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "DIFTERIETOXOÏDE, GEADSORBEERD, GEINACTIVEERD",
    "PERTACTINE (69KD Buitenmembraan Proteine)",
    "PERTUSSIS, FILAMENTEUS HAEMAGGLUTININE, GEADSORBEERD",
    "PERTUSSISTOXOÏDE, GEINACTIVEERD, GEADSORBEERD",
    "POLIOMYELITIS VIRUS TYPE I (Mahoney Stam) MONOVALENT, GEÏNACTIVEERD",
    "POLIOMYELITIS VIRUS TYPE II (MEF-1 Stam) MONOVALENT, GEÏNACTIVEERD",
    "POLIOMYELITIS VIRUS TYPE III (Saukett Stam) MONOVALENT, GEÏNACTIVEERD",
    "TETANUSTOXOÏDE, GEADSORBEERD, GEINACTIVEERD"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h35123.pdf",
  "authorised_at": "2007/07/13",
  "procedure_number": "DE/H/0466/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "35123",
  "additional_monitoring": "N"
}

See everything about diphtherie-pertussis-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.